In HCM, TGF-β signaling has been long known for its upregulation in experimental models of myocardial infarction and cardiac hypertrophy (Frangogiannis, 2020; Teekakirikul et al., 2010). The gene discussed is TGFB1; the disease is cardiac hypertrophy.